Merck Misled USPTO In Singulair Patent Case: Teva

Generic-drug maker Teva Pharmaceuticals USA Inc. on Monday sought to compel Merck & Co. Inc. to divulge what Teva alleges is prior art information that could undermine a patent for the...

Already a subscriber? Click here to view full article